Corrective Assignment to Correct the Receiving Party Address Previously Recorded at Reel: 063643 Frame: 0294. Assignor(S) Hereby Confirms the Change of Name .

Recorded: 2023-05-24 Pages: 5

Assignor

ANTIGEN EXPRESS, INC

Executed: 2019-12-27

Assignee

NUGENEREX IMMUNO-ONCOLOGY, INC.

450 CENTURY PKWY, SUITE 250, ALLEN, TEXAS, 75013

Covered Property (1)

Ii-KEY/HER-2/NEU HYBRID CANCER VACCINE

Patent: 8,889,143 →

Application: 12/635,656 →

Publication: US 2010/0150953

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.